Sangamo Therapeutics Inc (NASDAQ: SGMO) kicked off on Friday, down -6.45% from the previous trading day, before settling in for the closing price of $0.53. Over the past 52 weeks, SGMO has traded in a range of $0.38-$2.84.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 10.57%. While this was happening, its average annual earnings per share was recorded 31.67%. With a float of $328.24 million, this company’s outstanding shares have now reached $336.49 million.
Sangamo Therapeutics Inc (SGMO) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Sangamo Therapeutics Inc is 2.45%, while institutional ownership is 18.72%.
Sangamo Therapeutics Inc (SGMO) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.11 earnings per share (EPS), lower than consensus estimate (set at -0.05) by -0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 31.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 73.79% during the next five years compared to 10.57% growth over the previous five years of trading.
Sangamo Therapeutics Inc (NASDAQ: SGMO) Trading Performance Indicators
Take a look at Sangamo Therapeutics Inc’s (SGMO) current performance indicators. Last quarter, stock had a quick ratio of 0.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.44, a number that is poised to hit -0.01 in the next quarter and is forecasted to reach -0.32 in one year’s time.
Technical Analysis of Sangamo Therapeutics Inc (SGMO)
The latest stats from [Sangamo Therapeutics Inc, SGMO] show that its last 5-days average volume of 10.86 million was superior to 6.12 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 71.04%.
During the past 100 days, Sangamo Therapeutics Inc’s (SGMO) raw stochastic average was set at 29.18%, which indicates a significant decrease from 64.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0521 in the past 14 days, which was higher than the 0.0478 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5671, while its 200-day Moving Average is $0.6125. Now, the first resistance to watch is $0.5190. This is followed by the second major resistance level at $0.5421. The third major resistance level sits at $0.5562. If the price goes on to break the first support level at $0.4818, it is likely to go to the next support level at $0.4677. Assuming the price breaks the second support level, the third support level stands at $0.4446.
Sangamo Therapeutics Inc (NASDAQ: SGMO) Key Stats
The company with the Market Capitalisation of 166.87 million has total of 336,495K Shares Outstanding. Its annual sales at the moment are 57,800 K in contrast with the sum of -97,940 K annual income. Company’s last quarter sales were recorded 580 K and last quarter income was -34,930 K.
